Idéal Investisseur
Français English
CAC 40 : Market closed
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35 (last close)
Last close data
🏠 Home   ➤    Stock news

Eurofins Scientific: A New Buyback Program Covering 4.5% of Capital

Eurofins Scientific announces the launch of its seventh buyback program for its own shares, with a maximum amount representing 4.5% of its share capital. This program, starting April 24, 2026, follows the sixth program which took place between April 25, 2025, and April 23, 2026.


Eurofins Scientific: A New Buyback Program Covering 4.5% of Capital

Terms and Duration of the Program

The new buyback program will extend until April 23, 2027, at the latest. The first tranche, managed by an independent financial services provider, will begin on April 24, 2026, and end on June 23, 2026, with a maximum volume of 7,920,000 shares, representing 4.5% of the current share capital. The provider is authorized to make purchases on regulated markets, limited to 25% of the average daily transaction volume of the last twenty trading days, as well as block purchases on the free market. The total volume of shares repurchased on any trading day will not exceed 50% of the average daily volume of the last twenty trading days.

Use of Repurchased Shares

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

The shares acquired under this program will be used to cover the company's long-term incentive plans. They may also be cancelled, used to partially finance acquisitions, or used for other purposes approved by the board of directors and authorized by the general meeting held on April 23, 2026. Eurofins may suspend this program at any time depending on market conditions and changes in its investment strategy.



Sector Santé · Pharmacie Services médicaux


Assurance vie

Context

Period
  • Period: 2025
Key reported figures
  • Revenue: 7 296 M€
  • Revenue growth: 5,0%
  • EBITDA: 1 561 M€
  • EBITDA margin: 21,4%
  • Net income: 473 M€
  • Free cash flow: 876 M€
  • Net debt: 3 641 M€
  • Dividend per share: 0,72 €
Guidance from the release
  • Nous sommes satisfaits d’avoir atteint nos objectifs 2025 et de démontrer la solidité du portfolio Eurofins.
  • La performance 2025 est soutenue par la croissance organique et l’expansion des marges, avec un flux de trésorerie libre robuste et un endettement maîtrisé.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit